Products for Research Use Only
RegisterLogin

Voxalatamab

CAT: 0804-HY-P99517-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99517-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody targeting PSMA and CD3. Voxalatamab attacks PSMA-expressing tumor cells by activating T cells. Voxalatamab has anticancer activity and is being studied for the treatment of solid tumors such as prostate cancer[1][2].
CAS Number
2411871-58-2
Product Name Alternative
JNJ-63898081; JNJ-081
UNSPSC
12352203
Target
CD3; PSMA
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/voxalatamab.html
Purity
99.90
Solubility
10 mM in DMSO
Smiles
[Voxalatamab]
Molecular Weight
(144.68 kDa)
References & Citations
[1]Jonas S Heitmann, et al. Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives. Cancers (Basel) . 2021 Feb 1;13 (3) :549.|[2]Lim EA, et al. Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2023 Jun;21 (3) :366-375.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
BA5865-1Voxalatamab
GTR18337815-01Voxalatamab Antibody
WA3804Research Grade Voxalatamab
KBI1775KRIBIOLISA™ Voxalatamab ELISA
E55B1282Voxalatamab (Reference antibody)
GTR18697317-01Voxalatamab Human Monoclonal Antibody
A135527Voxalatamab Biosimilar (Monoclonal, Ig (G4-kappa_G4-lambda) )
PX-TA1757-01Voxalatamab Biosimilar - Anti-PSMA & CD3e mAb - Research Grade

Popular Products